Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer
2011 · British Journal of Cancer · 47 citations
https://doi.org/10.1038/bjc.2011.433
I
Isabelle Cadron
AZ Turnhout(BE)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
79
Papers
2.0K
Citations
22
h-index
28
i10-index
Isabelle Cadron is an academic researcher from AZ Turnhout. The author has contributed to research in topics: Ovarian cancer diagnosis and treatment & Endometrial and Cervical Cancer Treatments & Intraperitoneal and Appendiceal Malignancies. The author has an h-index of 22, co-authored 68 publications.
Papers by this author
worksProteomic biomarkers predicting lymph node involvement in serum of cervical cancer patients. Limitations of SELDI-TOF MS
2012 · Proteome Science · 12 citations
https://doi.org/10.1186/1477-5956-10-41
Longer-Term Safety And Efficacy Of Selinexor Maintenance Therapy For Patients With TP53wt Advanced Or Recurrent Endometrial Cancer: Follow-Up Subgroup Analysis Of The ENGOT-EN5/GOG-3055/SIENDO Study
2025 · International Journal of Gynecological Cancer · 2 citations
https://doi.org/10.1016/j.ijgc.2024.100081
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat